Levodopa and Movement Disorders in Williams Syndrome
Author Information
Author(s): Nikolai Gil D. Reyes, Nathaniel Bendahan, Emily Swinkin, Anthony E. Lang, Anne S. Bassett
Primary Institution: University of Toronto
Hypothesis
Can levodopa effectively treat movement disorders and schizoaffective disorder in individuals with Williams syndrome?
Conclusion
Levodopa may be a safe and effective treatment for movement disorders associated with antipsychotic use in individuals with Williams syndrome.
Supporting Evidence
- Both patients had treatment-resistant schizoaffective disorder requiring multiple antipsychotic trials.
- Levodopa treatment led to marked improvement in parkinsonism and partial improvement in dystonia.
- The study suggests potential shared underlying mechanisms for movement disorders in Williams syndrome.
Takeaway
This study looked at two women with a rare condition called Williams syndrome who got better when they took a medicine called levodopa for their movement problems.
Methodology
The study involved detailed case reports of two adults with Williams syndrome, reviewing their medical histories, treatments, and responses to levodopa.
Limitations
The study is based on only two case reports, limiting generalizability.
Participant Demographics
Both participants were middle-aged women with confirmed Williams syndrome.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website